FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称RISANKIZUMAB
异名/同义词655066-01
ABBV-066
BI-655066
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 23 SUBUNIT P19) (HUMAN-MUS MUSCULUS HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL23A (INTERLEUKIN 23 SUBUNIT ALPHA, IL-23A, IL23 SUBUNIT P19, IL23P19)), HUMANIZED MONOCLONAL ANTIBODY
RISANKIZUMAB
RISANKIZUMAB [INN]
RISANKIZUMAB [JAN]
RISANKIZUMAB [MI]
RISANKIZUMAB [USAN]
RISANKIZUMAB [WHO-DD]
RISANKIZUMAB RZAA [WHO-DD]
RISANKIZUMAB-RZAA
SKYRIZI
CAS登记号1612838-76-2
物质唯一标识(Unique Ingredient Identifier)90ZX3Q3FR7
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System